Untangling Pharma Supply Chains
Pharma supply chains in India have a lot of ground to cover before becoming at par with their counterparts in the developed…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
A Green Llight for GST
In India, pharma logistics is riddled with several speed breakers: poor infrastructure, multiplicity of state and central taxes,…
Falling in Line
It has been a year since the new EU GDP guidelines came into force. As the industry moves towards an increased focus on quality,…
Product launches and patent expiries to push MDD treatment market by 2023: GlobalData
MDD treatment market achieved sales of approximately $9.3 billion in 2013
June 16-30, 2014
{source}<div data-configid="5690019/8355160" style="width: 600px; height: 396px;" class="issuuembed"></div><script…
Inaugural LifeSight report to be launched at MicroScience 2014
Funding, collaborations and technologies all discussed in comprehensive new report
Modi’s Mantra for Pharma
Leaders accross industries have high expectations from Prime Minister Narendra Modi. As the new government gets down to business,…
‘Industry needs more a predictable IP environment’
It is after a long hiatus that India has got a government at the centre with a clear majority. This is an opportunity that Prime…
‘Less government and more governance will do the magic’
We have been fortunate to work closely with Prime Minister Narendra Modi during his tenure as the Chief Minister of Gujarat,…
‘Pharma manufacturing should be excise free’
If the government wants to make healthcare more affordable then all pharma manufacturing should be excise free like the Baddi…